MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/arclin/acaf100

Медицинская библиотека · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026

Precision Neuromodulation for Diabetes-Associated Cognitive Decline: a Transcranial Electrical Stimulation Approach.

Mohammadi Roghayeh, Alipour Ahmad

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Type 3 Diabetes (T3DM), marked by brain insulin resistance, is increasingly linked to neurocognitive decline and Alzheimer's pathogenesis, necessitating novel non-pharmacological interventions. This study investigated anodal transcranial direct current stimulation (tDCS) targeting the left DLPFC (F3 region) to improve cognitive deficits in insulin-dependent diabetic patients with diabetes-associated cognitive decline (DACD).

METHODS

This study utilized a randomized, double-blind, two-group clinical trial design. Diabetic patients aged 60-80 years in Tehran and Bonab experiencing brain fog and cognitive decline constituted the target population. Recruitment and execution occurred from autumn 2024 to spring 2025. A purposive sampling method selected 23 matched participants per group, adhering to strict inclusion/exclusion criteria. Participants were then randomly assigned to either the experimental or control group. The experimental group received 30 tDCS sessions. Cognitive status and memory were assessed using the mini-mental state examination as the primary outcome and the prospective and retrospective memory questionnaire as a supplementary measure. Repeated Measures ANOVA analyzed the data.

RESULTS

The results indicated that tDCS administered to the DLPFC in the experimental cohort significantly enhanced overall cognitive function and reduced subjective memory complaints (p < .01). Additionally, a statistically significant reduction in glycated hemoglobin was observed across nearly all participants in the experimental group (p < .01).

CONCLUSION

These findings indicate that tDCS presents a promising, non-invasive therapeutic approach. It demonstrates potential for enhancing cognitive function in patients with DACD and for facilitating improved long-term glycemic control. This highlights the role of brain neuromodulation as a component in the management of diabetes-related complications.

Для цитирования: Mohammadi Roghayeh, Alipour Ahmad. Precision Neuromodulation for Diabetes-Associated Cognitive Decline: a Transcranial Electrical Stimulation Approach.. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 2026. DOI: 10.1093/arclin/acaf100.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.